In the medtech industry new products stand for a large share of profits. The Arthur D. Little recent global Innovation Excellence study identified that innovation systems impact significantly the profitability and the time-to-market for new product development thus demanding high performance in this domain.
To address current and future industry challenges we revealed six imperatives for excellence in innovation management which are critical e.g. offering complete solutions covering entire healthcare work flows or managing regulatory complexity. Nevertheless each company's journey towards innovation excellence needs to be based on the own prerequisites. Applying the power of innovation will be imperative to becoming a winner in the future landscape of medtech and the race is on to claim the innovation leadership top spot.